Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glenmark Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532296NSE Symbol: GLENMARKP/E(TTM):30.82
ISIN Demat:INE935A01035Div & Yield %:0.13EPS(TTM):61.81
Book Value(Rs):868.3164333Market Cap ( Cr.):53763.49Face Value(Rs):1
    Change Company 
Date Headline
04-Jul-25 Glenmark Pharmaceuticals Ltd spurts 1.6%, rises for fifth straight session
02-Jul-25 Glenmark Pharmaceuticals Ltd up for third straight session
02-Jul-25 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Copy of Newspaper Publication
02-Jul-25 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Copy of Newspaper Publication
01-Jul-25 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Shareholders meeting
01-Jul-25 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Shareholders meeting
24-Jun-25 Glenmark Pharmaceuticals launches TEVIMBRA® in India
24-Jun-25 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
20-Jun-25 Glenmark Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Cessation
20-Jun-25 Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Cessation
<< < 1 2 3 4   > >>